Prime Global continues its expansion with the launch of their new Prime Access Consultancy, building on their existing capabilities to deliver to exceptional solutions for the payer industry.
Sue O’Leary; Vice President, Prime Access who leads a team of dedicated consultants states: “The science that is developing rapidly in areas such as oncology and rare diseases, presents new challenges in communicating value – we have experience first-hand in the daily decisions that payers have to make, as well as experience within the pharmaceutical industry as part of drug development teams. Everyone has difficult decisions to make. Clarity of evidence is key. At Prime Access, our value proposition is clear; our solutions are designed by experience!”
The team will draw on their experience working both within payer decision bodies and the pharmaceutical industry. This will enable them to support the current services provided by the Prime Global medical communication agencies and create new relationships with clients who value consultants with first-hand knowledge in the market access industry.
Graeme Peterson, Founder, Group Chairman and CEO of Prime Global adds, “Our new consultancy, Prime Access, has developed organically from the growth of our clients’ needs. We are extremely excited to be involved in the continuation of creating brilliant scientific communications that Prime Global is renowned for. Prime Access’ priority is to help navigate the difficulties clients face by driving strategic decisions and providing communications that resonate with both a payer and policy maker audience.”